Skip to main content
. 2023 Mar 15;12(6):2295. doi: 10.3390/jcm12062295

Table 2.

Data according to the presence or absence of ARBs.

ARB (+)
N = 22
ARB (-)
N = 39
p-Value
Gender (M/F) 17/5 27/12 0.509
Age (years) 64.3 ± 10.2 69.8 ± 11.7 0.070
DM (%) 27 28 0.939
Smoking (%) 55 44 0.419
BMI 20.7 ± 2.9 21.3 ± 3.0 0.428
HD vintage (months) 100.9 ± 54.6 90.4 ± 61.1 0.506
sBP (mmHg) 154.7 ± 10.9 146.6 ± 17.5 0.061
dBP (mmHg) 84.3 ± 10.2 81.7 ± 11.7 0.406
Pulse pressure (mmHg) 70.2 ± 12.4 64.7 ± 12.2 0.112
Ca (mg/dL) 9.3 ± 1.1 8.9 ± 0.9 0.139
IP (mg/dL) 6.1 ± 1.2 5.9 ± 1.3 0.563
Ca × IP 56.3 ± 10.4 52.8 ± 13.1 0.277
Intact PTH (ng/dL) 350.5 ± 198.9 270.6 ± 211.4 0.151
Hct (%) 30.9 ± 4.0 32.6 ± 4.5 0.154
Alb (g/dL) 3.7 ± 0.3 3.6 ± 0.4 0.624
β2MG (mg/L) 30.2 ± 6.7 28.5 ± 6.0 0.319
Log hsCRP 2.35 ± 1.67 1.85 ± 1.33 0.205
Fibrinogen (mg/dL) 300 ± 77.3 336.2 ± 86.2 0.107
CCB (%) 63.6 51.3 0.419
αβ-Blocker (%) 27.3 28.2 0.936

ARB: angiotensin II receptor blockade; DM: diabetes mellitus; BMI: body mass index; HD: hemodialysis; BP: blood pressure; Ca: calcium; IP: inorganic phosphate; iPTH: intact parathyroid hormone; Hct: hematocrit; Alb: albumin; β2MG: β2-microglobulin; hsCRP: high-sensitive C-reactive protein; CCB: calcium channel blocker.